Engel: Trump "Failed to Offer Better Deal" on Prescription Drug Pricing

Engel: Trump “Failed to Offer Better Deal” on Prescription Drug Pricing

Congressman Eliot Engel, a top member on the House Energy and Commerce Committee, issued the following statement on today’s speech by President Trump on prescription drug pricing:

“Today, President Trump had an opportunity to champion meaningful, comprehensive action for American consumers struggling with the rising costs of prescription drugs – and he failed.

“This is nothing new for the GOP. Earlier this week, House Republicans said no to even considering an ambitious Democratic plan to address the high cost of drugs. Last month, in the Energy and Commerce Committee, they voted to block an amendment that would require the Department of Health and Human Services to simply examine the rising price of the overdose reversal drug naloxone.

“And back in October,when I and other Energy and Commerce Democrats voted in favorof allowing Medicare to negotiate lower drug prices—something the President once claimed to support—the GOP voted it down. That proposal was, unsurprisingly, absent from President Trump’s speech today – another in a long list of broken promises.

“Rising prescription drug prices are a key concern of millions of American seniors and working families. Prices of many medications that have been on the market for decades are surging. Medication for Americans with chronic conditions more than doubled in price over the past decade to nearly $13,000 – taking up four-fifths of the average Social Security retirement benefit.

“These rising costs have real implications for working families: the Kaiser Family Foundation found that about a quarter of Americans didn’t fill a prescription in the previous year because of the prohibitive cost.

“This cannot stand. Americans demand a better deal – and today, President Trump failed to offer one.”